Drug profile · INN
pramipexole
APO-PRAMIPEXOLE
pramipexole (APO-PRAMIPEXOLE) is a d2-like dopamine receptor agonist. Associated with Alphapharm Pty Ltd.
EMA: approved TGA: approved NMPA: clinical trials Nervous system (N04) N04BC05
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — pramipexole
- Class
- Nervous system (N04)
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.89
Quick answer
pramipexole (APO-PRAMIPEXOLE) is a d2-like dopamine receptor agonist. Associated with Alphapharm Pty Ltd.
Key facts
INN pramipexole
Brand APO-PRAMIPEXOLE
Mechanism D2-like dopamine receptor agonist
Therapeutic class Nervous system (N04)
ATC code N04BC05
Originator Alphapharm Pty Ltd
Mechanism of action
D2-like dopamine receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pramipexole?
pramipexole (APO-PRAMIPEXOLE) is a d2-like dopamine receptor agonist. Associated with Alphapharm Pty Ltd.
What is the brand name for pramipexole?
APO-PRAMIPEXOLE is a marketed brand name for pramipexole. Check FDA Drugs@FDA for the current US label holder and prescribing information.